126 
additions would prevent the use of perform-
ance-enhancing substances by high school, 
college, or professional athletes. 
‘‘(d) DELEGATION.—The Director may dele-
gate the administration of this subtitle to any 
other appropriate agency of the Federal Gov-
ernment. 
‘‘SEC. 726. ENFORCEMENT BY THE FEDERAL TRADE COM-
MISSION. 
‘‘(a) UNFAIR OR DECEPTIVE ACTS OR PRAC-
TICES.—A violation of section 724 shall be 
treated as a violation of section 18 of the Fed-
eral Trade Commission Act (15 U.S.C. 57a) re-
garding unfair or deceptive acts or practices. 
‘‘(b) POWERS OF COMMISSION.— 
‘‘(1)
IN
GENERAL.—The
Commission 
shall issue and enforce the regulations 
for the enforcement of section 724 in the 
same manner, by the same means, and 
with the same jurisdiction, powers, and 
duties as though all applicable terms and 
provisions of the Federal Trade Commis-
sion Act (15 U.S.C. 41 et seq.) were incor-
porated into and made a part of this sub-
title. Any person who violates such regu-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00126
Fmt 6652
Sfmt 6402
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
127 
lations shall be subject to the penalties 
and entitled to the privileges and immu-
nities provided in that Act. 
‘‘(2)
ENHANCED
PENALTY
FOR
VIOLA-
TIONS.—Notwithstanding
subsection
(a) 
and the Federal Trade Commission Act, 
in the case of a person who violates sec-
tion 724, the Commission may, in its dis-
cretion, seek a civil penalty for such vio-
lation in an amount, as determined by 
the
Commission,
of
not
more
than 
$1,000,000 for each violation of section 
724. 
‘‘(3) GENERAL AUTHORITY.—Nothing in 
this subtitle shall be construed to limit 
the authority of the Commission under 
any other provision of law. 
‘‘SEC. 727. REPORTS TO CONGRESS. 
‘‘(a) FIRST LEAGUE REPORT.— 
‘‘(1)
IN
GENERAL.—Not
later
than
months after completion of a professional 
sports league’s first season of play after 
the effective date of this subtitle, each 
major professional league shall transmit 
to the Committee on Commerce, Science, 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00127
Fmt 6652
Sfmt 6402
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
128 
and Transportation of the Senate and the 
Committee on Energy and Commerce and 
the Committee on Government Reform of 
the House of Representatives, a report on 
its testing policies and procedures. 
‘‘(2) CONTENTS.—The report required 
by this subsection shall contain— 
‘‘(A) a comparison of the major 
professional
league’s
testing
policy 
(including
its
adjudication
proce-
dures) to that of the United States 
Anti-Doping Agency, emphasizing the 
differences between the policies and 
the rationales for the differences; and 
‘‘(B) aggregate data on the num-
ber of professional players tested by 
the major professional league and the 
prohibited
substances
detected
in 
samples or prohibited methods, in-
cluding
the
number
of
tests
con-
ducted during the season of play and 
during the off-season. 
‘‘(b)
BIENNIAL
LEAGUE
REPORTS.—Each 
major professional league shall transmit to 
the Committee on Commerce, Science, and 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00128
Fmt 6652
Sfmt 6402
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
129 
Transportation of the Senate and the Com-
mittee on Energy and Commerce and the 
Committee on Government Reform of the 
House of Representatives, on a biennial basis, 
a report containing the data and analysis re-
quired in subsection (a) for each of the 2 prior 
years. 
‘‘(c) ONDCP REPORT.—Not later than 1 
year after the date of enactment of this sub-
title, and subsequently thereafter as deter-
mined appropriate by the Director, the Direc-
tor shall report to the Committee on Com-
merce, Science, and Transportation of the 
Senate and the Committee on Energy and 
Commerce and the Committee on Govern-
ment Reform of the House of Representatives, 
recommendations for improving any Federal 
law governing controlled substances as may 
be necessary for reducing the use of steroids 
and
other
performance-enhancing
sub-
stances. 
‘‘SEC.
728.
PROMULGATION
OF
STANDARDS
BY
UNITED 
STATES BOXING COMMISSION. 
‘‘Upon the later of 12 months after enact-
ment of this subtitle or 12 months after the es-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00129
Fmt 6652
Sfmt 6402
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
130 
tablishment of the United States Boxing Com-
mission pursuant to Federal law, that com-
mission shall, in consultation with the Asso-
ciation of Boxing Commissions and the United 
States Anti-Doping Agency, promulgate uni-
form performance-enhancing substance test-
ing standards for professional boxing that are 
consistent with section 724. 
‘‘SEC. 729. STUDY ON COLLEGE TESTING POLICIES AND 
PROCEDURES. 
‘‘(a)
STUDY.—The
Government
Account-
ability Office shall conduct a study on the use 
of performance-enhancing substances by col-
lege athletes which shall examine the prohib-
ited substance policies and testing proce-
dures of intercollegiate athletic associations 
and college and university athletic depart-
ments. 
‘‘(b) REPORT.— 
‘‘(1)
SUBMISSION
TO
CONGRESS.—Not 
later than 1 year after the date of enact-
ment of this subtitle, the Government Ac-
countability Office shall transmit a re-
port
to
the
Committee
on
Commerce, 
Science, and Transportation of the Sen-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00130
Fmt 6652
Sfmt 6402
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
131 
ate and the Committee on Energy and 
Commerce and the Committee on Govern-
ment Reform of the House of Representa-
tives. 
‘‘(2) CONTENTS.—The report required 
by this subsection shall— 
‘‘(A) assess the adequacy of the 
testing policies and procedures de-
scribed in subsection (a) in detecting 
and preventing the use of perform-
ance-enhancing substances; and 
‘‘(B) include recommendations to 
Congress
regarding
expanding
the 
application of the regulations issued 
pursuant
to
this
subtitle
to
such 
intercollegiate
and
interscholastic 
athletic associations. 
‘‘SEC. 730. COMMISSION ON HIGH SCHOOL AND COLLE-
GIATE ATHLETICS. 
‘‘(a) COMMISSION.—The Director shall es-
tablish a commission on high school and colle-
giate athletics. 
‘‘(b) REPORT.—Not later than 1 year after 
the date of enactment of this subtitle, the 
commission shall report to Congress— 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00131
Fmt 6652
Sfmt 6402
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
132 
‘‘(1) findings on the use of steroids 
and
other
performance-enhancing
sub-
stances
in
high
school
and
collegiate 
sports; and 
‘‘(2)
recommendations
for
reducing 
their use. 
‘‘SEC. 731. SENSE OF CONGRESS. 
‘‘It is the sense of Congress that— 
‘‘(1) professional sports leagues not 
regulated by this subtitle should adhere 
to the drug testing standards established 
in this subtitle; 
‘‘(2) all professional sports should im-
plement policies and procedures for the 
testing
of
the
use
of
prohibited
sub-
stances or the detection of prohibited 
methods by professional athletes that en-
sure that American professional sports 
leagues are world leaders in the effort to 
keep steroids and other performance-en-
hancing drugs out of sports; 
‘‘(3) all professional sports should im-
plement policies and procedures that ad-
dress
the
development
of
designer 
steroids
and
emerging
methods
for 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00132
Fmt 6652
Sfmt 6402
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
133 
doping, including gene doping, that en-
hance sports performance, are potential 
or actual health risks, and are contrary 
to the spirit of the sport; and 
‘‘(4) each major professional league 
should produce and publicize public serv-
ice announcements regarding the health 
and safety consequences of steroids and 
other
similar
performance-enhancing 
substances on children and teenagers. 
‘‘SEC. 732. EFFECTIVE DATE. 
‘‘This subtitle shall take effect 1 year after 
the date of enactment of this subtitle.’’. 
(b) CONFORMING AMENDMENTS.—The Office 
of National Drug Control Policy Reauthoriza-
tion Act of 1998 (Public Law 105–277; 21 U.S.C. 
1701 et seq.) is further amended by striking 
‘‘title’’ each place it appears and inserting 
‘‘subtitle’’— 
(1) in section 701; 
(2) in section 702; 
(3) in section 703(b)(2); 
(4) in section 704(d)(1); and 
(5) in the first and second sentences 
of section 705(a)(2)(A). 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00133
Fmt 6652
Sfmt 6402
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
134 
SECTION 1. SHORT TITLE; TABLE OF CONTENTS. 
(a) SHORT TITLE.—This Act may be cited as the ‘‘Of-
fice of National Drug Control Policy Reauthorization Act 
of 2005’’. 
(b) TABLE OF CONTENTS.—The table of contents for 
this Act is as follows: 
Sec. 1. Short title; table of contents. 
Sec. 2. Amendment of Office of National Drug Control Policy Reauthorization 
Act of 1998. 
Sec. 3. Repeal of termination provision. 
Sec. 4. Amendments to definitions. 
Sec. 5. Amendments relating to establishment of Office of National Drug Control 
Policy and designation of officers. 
Sec. 6. Amendments relating to appointment and duties of Director and Deputy 
Director. 
Sec. 7. Amendments relating to coordination with other agencies. 
Sec. 8. Development, submission, implementation, and assessment of National 
Drug Control Strategy. 
Sec. 9. High Intensity Drug Trafficking Areas Program. 
Sec. 10. Funding for certain High Intensity Drug Trafficking Areas. 
Sec. 11. Amendments relating to Counter-Drug Technology Assessment Center. 
Sec. 12. National youth antidrug media campaign. 
Sec. 13. Drug interdiction. 
Sec. 14. Awards for demonstration programs by local partnerships to shut down 
illicit drug market hot-spots by deterring drug dealers or alter-
ing the dynamic of drug sales. 
Sec. 15. Awards for demonstration programs by local partnerships to coerce absti-
nence in chronic hard-drug users under community supervision 
through the use of drug testing and sanctions. 
Sec. 16. Authorization of appropriations. 
Sec. 17. Technical amendments and repeal. 
Sec. 18. Requirement for disclosure of Federal sponsorship of all Federal adver-
tising or other communication materials. 
Sec. 19. Policy relating to syringe exchange programs. 
SEC. 2. AMENDMENT OF OFFICE OF NATIONAL DRUG CON-
TROL POLICY REAUTHORIZATION ACT OF 
1998. 
Except as otherwise expressly provided, whenever in 
this Act an amendment or repeal is expressed in terms of 
an amendment to, or repeal of, a section or other provision, 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00134
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
135 
the reference shall be considered to be made to a section or 
other provision of the Office of National Drug Control Pol-
icy Reauthorization Act of 1998 (Public Law 105–277; 21 
U.S.C. 1701 et seq.). 
SEC. 3. REPEAL OF TERMINATION PROVISION. 
Section 715 (21 U.S.C. 1712) is repealed, and the law 
shall read as if such section was never in effect. 
SEC. 4. AMENDMENTS TO DEFINITIONS. 
(a) AMENDMENTS TO DEFINITIONS.—Section 702 (21 
U.S.C. 1701) is amended— 
(1) in paragraph (1)— 
(A) by striking ‘‘and’’ at the end of sub-
paragraph (F); 
(B) by striking the period at the end of sub-
paragraph (G) and inserting ‘‘, including the 
testing of employees;’’; and 
(C) by adding at the end the following: 
‘‘(H) interventions for drug abuse and de-
pendence; and 
‘‘(I) international drug control coordination 
and cooperation with respect to activities de-
scribed in this paragraph.’’; 
(2) in paragraph (6), by adding before the pe-
riod at the end: ‘‘, including any activities involving 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00135
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
136 
supply reduction, demand reduction, or State and 
local affairs’’; 
(3) in paragraph (7)— 
(A) by striking ‘‘Agency’’ and inserting 
‘‘agency’’; 
(B) by striking ‘‘National Foreign Intel-
ligence Program,’’ and inserting ‘‘National Intel-
ligence Program,’’; and 
(C) by inserting a comma before ‘‘or Tac-
tical’’; 
(4) in paragraph (9), by striking ‘‘implicates’’ 
and inserting ‘‘indicates’’; 
(5) in paragraph (10)— 
(A) by adding ‘‘National Drug Control Pro-
gram agencies and’’ after ‘‘among’’ in subpara-
graph (B); 
(B) by striking ‘‘and’’ at the end of sub-
paragraph (B); 
(C) by striking the period at the end of sub-
paragraph (C) and inserting a semicolon; and 
(D) by adding at the end the following: 
‘‘(D) domestic drug law enforcement, in-
cluding domestic drug interdiction and law en-
forcement directed at drug users; and 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00136
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
137 
‘‘(E) coordination and enhancement of Fed-
eral, State, and local law enforcement initiatives 
to gather, analyze, and disseminate information 
and intelligence relating to drug control among 
domestic law enforcement agencies.’’; 
(6) in paragraph (11)— 
(A) by inserting before the semicolon in sub-
paragraph (A) the following: ‘‘, including— 
‘‘(i) 
law 
enforcement 
outside 
the 
United States; and 
‘‘(ii) source country programs, includ-
ing economic development programs pri-
marily intended to reduce the production or 
trafficking of illicit drugs’’; 
(B) by striking subparagraph (B) and in-
serting the following: 
‘‘(B) facilitating and enhancing the sharing 
of foreign and domestic information and law en-
forcement intelligence relating to drug produc-
tion and trafficking among National Drug Con-
trol Program agencies, and between those agen-
cies and foreign law enforcement agencies; and’’; 
(C) by striking ‘‘; and’’ at the end of sub-
paragraph (C) and inserting a period; and 
(D) by striking subparagraph (D); and 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00137
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
138 
(7) by adding at the end the following: 
‘‘(12) APPROPRIATE
CONGRESSIONAL
COMMIT-
TEES.—Except where otherwise provided, the term 
‘appropriate congressional committees’ means the 
Committee on the Judiciary, the Committee on Ap-
propriations, and the Caucus on International Nar-
cotics Control of the Senate and the Committee on 
Government Reform, the Committee on the Judiciary, 
and the Committee on Appropriations of the House of 
Representatives. 
‘‘(13) LAW ENFORCEMENT.—The term ‘law en-
forcement’ or ‘drug law enforcement’ means all efforts 
by a Federal, State, or local government agency to en-
force the drug laws of the United States or any State, 
including investigation, arrest, prosecution, and in-
carceration or other punishments or penalties.’’. 
(b) CONFORMING AMENDMENTS.—Section 703(b)(3) 
(21 U.S.C. 1702(b)(3)) is amended— 
(1) in subparagraph (A), by striking ‘‘(G)’’ and 
inserting ‘‘(I)’’; and 
(2) in subparagraph (C)— 
(A) by striking ‘‘through (C)’’ and inserting 
‘‘through (E)’’; 
(B) by striking ‘‘and subparagraph (D) of 
section 702(11)’’; and 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00138
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
139 
(C) by adding before the period at the end 
the following: ‘‘, and sections 707 and 708 of this 
Act’’. 
SEC. 5. AMENDMENTS RELATING TO ESTABLISHMENT OF 
OFFICE OF NATIONAL DRUG CONTROL POL-
ICY AND DESIGNATION OF OFFICERS. 
(a) RESPONSIBILITIES.—Paragraph (4) of section 
703(a) (21 U.S.C. 1702(a)) is amended to read as follows: 
‘‘(4) evaluate the effectiveness of the national 
drug control policy and the National Drug Control 
Program agencies’ programs, by developing and ap-
plying specific goals and performance measure-
ments.’’. 
(b) RANK OF DIRECTOR.—Section 703(b) (21 U.S.C. 
1702(b)) is amended in paragraph (1) by adding before the 
period the following: ‘‘, who shall hold the same rank and 
status as the head of an executive department listed in sec-
tion 101 of title 5, United States Code’’. 
(c) DEPUTY DIRECTORS.—Section 703(b) (21 U.S.C. 
1702(b)) is amended in paragraph (3)— 
(1) by striking ‘‘Office—’’ and inserting ‘‘Office 
the following additional Deputy Directors—’’; and 
(2) in subparagraph (B), by striking ‘‘who shall’’ 
and inserting the following: ‘‘who shall have substan-
tial experience and expertise in drug interdiction op-
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00139
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
140 
erations and other supply reduction activities, and 
who shall serve as the United States Interdiction Co-
ordinator and’’. 
SEC. 6. AMENDMENTS RELATING TO APPOINTMENT AND 
DUTIES OF DIRECTOR AND DEPUTY DIREC-
TOR. 
(a) DESIGNATION
OF OTHER OFFICERS.—Section 
704(a)(3) (21 U.S.C. 1703(a)(3)) is amended— 
(1) by striking ‘‘permanent employee’’ and in-
serting ‘‘officer or employee’’; and 
(2) by striking ‘‘serve as the Director’’ and in-
serting ‘‘serve as the acting Director’’. 
(b) RESPONSIBILITIES OF DIRECTOR.—Section 704(b) 
(21 U.S.C. 1703(b)) is amended— 
(1) in paragraph (4), by striking ‘‘Federal de-
partments and agencies engaged in drug enforce-
ment,’’ and inserting ‘‘National Drug Control Pro-
gram agencies,’’; 
(2) in paragraph (7), by inserting after ‘‘Presi-
dent’’ the following: ‘‘and the appropriate congres-
sional committees’’; 
(3) in paragraph (13), by striking ‘‘(beginning 
in 1999)’’; 
(4) in paragraph (14)— 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00140
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
141 
(A) by striking ‘‘Appropriations’’ and all 
that follows through ‘‘Senate’’ and inserting ‘‘ap-
propriate congressional committees’’; and 
(B) by striking ‘‘and’’ after the semicolon at 
the end; 
(5) in paragraph (15), by striking subparagraph 
(C) and inserting the following: 
‘‘(C) supporting the substance abuse infor-
mation clearinghouse administered by the Ad-
ministrator of the Substance Abuse and Mental 
Health Services Administration and established 
in section 501(d)(16) of the Public Health Serv-
ice Act by— 
‘‘(i) encouraging all National Drug 
Control Program agencies to provide all ap-
propriate and relevant information; and 
‘‘(ii) supporting the dissemination of 
information to all interested entities;’’; and 
(6) by inserting at the end the following: 
‘‘(16) shall coordinate with the private sector to 
promote private research and development of medica-
tions to treat addiction; 
‘‘(17) shall seek the support and commitment of 
State and local officials in the formulation and im-
plementation of the National Drug Control Strategy; 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00141
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS
142 
‘‘(18) shall monitor and evaluate the allocation 
of resources among Federal law enforcement agencies 
in response to significant local and regional drug 
trafficking and production threats; 
‘‘(19) shall submit an annual report to Congress 
detailing how the Office of National Drug Control 
Policy has consulted with and assisted State and local 
governments with respect to the formulation and im-
plementation of the National Drug Control Strategy 
and other relevant issues; and 
‘‘(20) shall, within one year after the date of the 
enactment of the Office of National Drug Control Pol-
icy Reauthorization Act of 2005, report to Congress 
on the impact of each Federal drug reduction strategy 
upon the availability, addiction rate, use rate, and 
other harms of illegal drugs.’’. 
(c) SUBMISSION
OF DRUG CONTROL BUDGET RE-
QUESTS.—Section 704(c)(1) is amended by adding at the 
end the following: 
‘‘(C) CONTENT OF DRUG CONTROL BUDGET 
REQUESTS.—A drug control budget request sub-
mitted by a department, agency, or program 
under this paragraph shall include all requests 
for funds for any drug control activity under-
taken by that department, agency, or program, 
VerDate Aug 31 2005 
23:52 Mar 03, 2006
Jkt 049200
PO 00000
Frm 00142
Fmt 6652
Sfmt 6203
E:\BILLS\H2829.RH
H2829
jcorcoran on PROD1PC62 with BILLS